Brian T. Palmisano MD MD, PhD
Preventive Cardiology
Fellow, Cardiovascular Medicine
Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 650-498-6205
Dr. Palmisano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2021 - 2025- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2018 - 2021
Vanderbilt University School of MedicineClass of 2018
University of RochesterBS, BA, Biochemistry, Chemistry, Summa cum laude, Highest Honors, 2005 - 2009
Certifications & Licensure
CA State Medical License 2019 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 2 citationsGenome-Wide Genetic Associations Prioritize Evaluation of Causal Mechanisms of Atherosclerotic Disease Risk.Thomas Quertermous, Daniel Yuhang Li, Chad S Weldy, Markus Ramste, Disha Sharma
Arteriosclerosis, Thrombosis, and Vascular Biology. 2024-02-01 - Another Use for Polygenic Risk Scores: Improving Risk Prediction for Heterozygous Familial Hypercholesterolemia.Brian T Palmisano, Joshua W Knowles
JACC. Advances. 2023-11-01 - 5 citationsHepatocyte Small Heterodimer Partner Mediates Sex-Specific Effects on Triglyceride Metabolism via Androgen Receptor in Male Mice.Brian T. Palmisano, Lin Zhu, Bridget Litts, Andreanna Burman, Sophia Yu
Metabolites. 2021-05-20
Press Mentions
Primary Prevention in HypercholesterolemiaSeptember 30th, 2024
Grant Support
- Gene Regulatory Mechanisms of the Coronary Artery Disease Gene PRDM16 on Smooth Muscle Cell Phenotypic ModulationSTANFORD UNIVERSITY2025–2029
- The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis RiskSTANFORD UNIVERSITY2023–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
